111 related articles for article (PubMed ID: 18752758)
21. Prevention of recurrent esophageal variceal hemorrhage: review and current recommendations.
Kravetz D
J Clin Gastroenterol; 2007; 41 Suppl 3():S318-22. PubMed ID: 17975483
[TBL] [Abstract][Full Text] [Related]
22. Comparative study between nadolol and 5-isosorbide mononitrate vs. endoscopic band ligation plus sclerotherapy in the prevention of variceal rebleeding in cirrhotic patients: a randomized controlled trial.
Romero G; Kravetz D; Argonz J; Vulcano C; Suarez A; Fassio E; Dominguez N; Bosco A; Muñoz A; Salgado P; Terg R
Aliment Pharmacol Ther; 2006 Aug; 24(4):601-11. PubMed ID: 16827811
[TBL] [Abstract][Full Text] [Related]
23. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis.
Merkel C; Bolognesi M; Sacerdoti D; Bombonato G; Bellini B; Bighin R; Gatta A
Hepatology; 2000 Nov; 32(5):930-4. PubMed ID: 11050041
[TBL] [Abstract][Full Text] [Related]
24. Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy.
Sauerbruch T; Mengel M; Dollinger M; Zipprich A; Rössle M; Panther E; Wiest R; Caca K; Hoffmeister A; Lutz H; Schoo R; Lorenzen H; Trebicka J; Appenrodt B; Schepke M; Fimmers R;
Gastroenterology; 2015 Sep; 149(3):660-8.e1. PubMed ID: 25989386
[TBL] [Abstract][Full Text] [Related]
25. Review article: the modern management of portal hypertension--primary and secondary prophylaxis of variceal bleeding in cirrhotic patients.
Garcia-Pagan JC; De Gottardi A; Bosch J
Aliment Pharmacol Ther; 2008 Jul; 28(2):178-86. PubMed ID: 18462268
[TBL] [Abstract][Full Text] [Related]
26. Secondary prophylaxis of variceal bleeding for cirrhotic patients: a multiple-treatments meta-analysis.
Shi KQ; Liu WY; Pan ZZ; Ling XF; Chen SL; Chen YP; Fan YC; Zheng MH
Eur J Clin Invest; 2013 Aug; 43(8):844-54. PubMed ID: 23725530
[TBL] [Abstract][Full Text] [Related]
27. Early identification of haemodynamic response to pharmacotherapy is essential for primary prophylaxis of variceal bleeding in patients with 'high-risk' varices.
Sharma P; Kumar A; Sharma BC; Sarin SK
Aliment Pharmacol Ther; 2009 Jul; 30(1):48-60. PubMed ID: 19392862
[TBL] [Abstract][Full Text] [Related]
28. Propranolol, isosorbide mononitrate and endoscopic band ligation - alone or in varying combinations for the prevention of esophageal variceal rebleeding.
Ahmad I; Khan AA; Alam A; Butt AK; Shafqat F; Sarwar S
J Coll Physicians Surg Pak; 2009 May; 19(5):283-6. PubMed ID: 19409159
[TBL] [Abstract][Full Text] [Related]
29. Somatostatin plus isosorbide 5-mononitrate versus somatostatin in the control of acute gastro-oesophageal variceal bleeding: a double blind, randomised, placebo controlled clinical trial.
Junquera F; López-Talavera JC; Mearin F; Saperas E; Videla S; Armengol JR; Esteban R; Malagelada JR
Gut; 2000 Jan; 46(1):127-32. PubMed ID: 10601068
[TBL] [Abstract][Full Text] [Related]
30. [Effects of isosorbide-5-mononitrate on esophageal manometry of cirrhotic patients with esophageal varices].
Lin XF; Wu JM; Lin XY; Chen MX; Zhu QH; Wu XL
Zhonghua Gan Zang Bing Za Zhi; 2005 Aug; 13(8):611-2. PubMed ID: 16092992
[No Abstract] [Full Text] [Related]
31. [Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding].
Wiest R; Lock G; Messmann H
Z Gastroenterol; 2002 Jul; 40(7):547-9. PubMed ID: 12122606
[No Abstract] [Full Text] [Related]
32. Somatostatin plus isosorbide mononitrate versus somatostatin in the control of acute gastro-oesophageal variceal bleeding: a double blind, randomised, placebo controlled trial.
Wong T; Wilkinson ML
Gastrointest Endosc; 2001 Aug; 54(2):275-6; discussion 275-6. PubMed ID: 11499390
[No Abstract] [Full Text] [Related]
33. The sixth Carlos E. Rubio Memorial Lecture. Prevention and treatment of variceal hemorrhage.
Bosch J
P R Health Sci J; 2000 Mar; 19(1):57-67. PubMed ID: 10761206
[TBL] [Abstract][Full Text] [Related]
34. Therapy for primary prophylaxis of varices: and, the winner is...?
Sharara AI; Rockey DC
Hepatology; 2003 Feb; 37(2):473-5; discussion 475-6. PubMed ID: 12540799
[No Abstract] [Full Text] [Related]
35. Endoscopic assessment of variceal volume and wall tension in cirrhotic patients: effects of pharmacological therapy.
Escorsell A; Bordas JM; Feu F; García-Pagán JC; Ginès A; Bosch J; Rodés J
Gastroenterology; 1997 Nov; 113(5):1640-6. PubMed ID: 9352867
[TBL] [Abstract][Full Text] [Related]
36. Medical decompressive therapy for prophylaxis of rebleeding.
Lebrec D
Digestion; 1998 Jul; 59 Suppl 2():48-9. PubMed ID: 9718420
[No Abstract] [Full Text] [Related]
37. Clinical trial: a randomized controlled study on prevention of variceal rebleeding comparing nadolol + ligation vs. hepatic venous pressure gradient-guided pharmacological therapy.
Villanueva C; Aracil C; Colomo A; Lopez-Balaguer JM; Piqueras M; Gonzalez B; Torras X; Guarner C; Balanzo J
Aliment Pharmacol Ther; 2009 Feb; 29(4):397-408. PubMed ID: 19006538
[TBL] [Abstract][Full Text] [Related]
38. Isosorbide mononitrate in the prevention of first variceal bleed in patients who cannot receive beta-blockers.
García-Pagán JC; Villanueva C; Vila MC; Albillos A; Genescà J; Ruiz-Del-Arbol L; Planas R; Rodriguez M; Calleja JL; González A; Solà R; Balanzó J; Bosch J;
Gastroenterology; 2001 Oct; 121(4):908-14. PubMed ID: 11606504
[TBL] [Abstract][Full Text] [Related]
39. [Importance of drug treatment to lower portal pressure in the therapy of variceal bleeding].
Schepke M
Dtsch Med Wochenschr; 2009 Sep; 134(37):1823-7. PubMed ID: 19728251
[No Abstract] [Full Text] [Related]
40. TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial.
Escorsell A; Bañares R; García-Pagán JC; Gilabert R; Moitinho E; Piqueras B; Bru C; Echenagusia A; Granados A; Bosch J
Hepatology; 2002 Feb; 35(2):385-92. PubMed ID: 11826413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
